Skip to main content
search

Early Clinical

Sign up

Latest resources

Featured resource

Upcoming early clinical webinars

Latest early clinical blogs

Meet our experts at the following events

All early clinical resources

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges

Certara Products - Simcyp, Clinical Pharmacology, Model Informed Drug Development, Modeling and Simulation - PBPK, Publication

2025 MFDS-KCDA Annual Conference

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Conference

From Insight to Impact: Certainty EMEA 2025

Certara Products, Certara Services, Blog

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

Certara Products - Certara IQ, Modeling and Simulation - QSP, Blog

The Next Chapter: What Generative AI Means for Medical Writers [Korean Webinar]

Webinar

Using M&S to Evaluate Oncology Drug Dosing

Clinical Pharmacology, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Therapeutic Specialties, Blog

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

Certara Products, Certara Products - Certara IQ, Certara Products - Phoenix, Certara Services, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Certara Products - Phoenix, Drug Development, Modeling and Simulation - PK/PD, Webinar

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Pharmacometrics, Rare and Neglected Diseases, Therapeutic Specialties, Publication

Supporting KalVista’s NDA Submission for a Novel HAE Treatment​

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Case Study

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Certara Products - Certara IQ, Certara Services, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Publication

Build investor confidence with science-backed strategy

Certara Services, Fact Sheet
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.